Det primære mål for vaccinens effekt var den andel af hundene, der udviklede antistoffer mod B. canis og B. rossi to uger efter den anden injektion.
The main measure of effectiveness was the proportion of the dogs that developed antibodies against B. canis and B. rossi two weeks after the second injection.